184 related articles for article (PubMed ID: 2904749)
21. Long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
Lijnen P; Fagard R; Staessen J; Lissens W; Amery A
J Cardiovasc Pharmacol; 1989 Aug; 14(2):319-25. PubMed ID: 2476608
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of doxazosin in the treatment of patients with mild or moderate essential hypertension and elevated levels of cholesterol.
Taylor SH
Am Heart J; 1991 Jan; 121(1 Pt 2):362-6. PubMed ID: 1824662
[TBL] [Abstract][Full Text] [Related]
23. Doxazosin in the treatment of essential hypertension in general medical practice in Latin America.
Silva H; Fonseca R; Marshall D
Am Heart J; 1991 Jan; 121(1 Pt 2):329-35. PubMed ID: 1824656
[TBL] [Abstract][Full Text] [Related]
24. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
[TBL] [Abstract][Full Text] [Related]
25. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
Lijnen P; Fagard R; Staessen J; Amery A
Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
[TBL] [Abstract][Full Text] [Related]
26. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
Ames RP; Kiyasu JY
J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
[TBL] [Abstract][Full Text] [Related]
27. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
Torvik D; Madsbu HP
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
[TBL] [Abstract][Full Text] [Related]
28. A double-blind comparative study of doxazosin and prazosin when administered with beta-blockers or diuretics.
de Planque BA
Am Heart J; 1991 Jan; 121(1 Pt 2):304-11. PubMed ID: 1670744
[TBL] [Abstract][Full Text] [Related]
29. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
[TBL] [Abstract][Full Text] [Related]
30. A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.
Daae LN; Westlie L
Blood Press; 1998 Jan; 7(1):39-45. PubMed ID: 9551876
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
Hayduk K; Schneider HT
Am J Cardiol; 1987 May; 59(14):95G-98G. PubMed ID: 2884860
[TBL] [Abstract][Full Text] [Related]
32. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
Talseth T; Westlie L; Daae LN
J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of doxazosin versus enalapril in the treatment of patients with mild-to-moderate hypertension.
Tan KW; Frise SA
Clin Ther; 1997; 19(3):459-70. PubMed ID: 9220210
[TBL] [Abstract][Full Text] [Related]
34. A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication.
Catalano M; Libretti A
Am Heart J; 1991 Jan; 121(1 Pt 2):367-71. PubMed ID: 1824663
[TBL] [Abstract][Full Text] [Related]
35. Doxazosin effects on insulin and glucose in hypertensive patients. The Finnish Multicenter Study Group.
Lehtonen A
Am Heart J; 1991 Apr; 121(4 Pt 2):1307-11. PubMed ID: 1826187
[TBL] [Abstract][Full Text] [Related]
36. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
[TBL] [Abstract][Full Text] [Related]
37. Doxazosin in patients with hypertension.
Conrad KA; Fagan TC; Mackie MJ; Mayshar PV; Lee S; Souhrada JF; Falkner FC; Lazar JD
Eur J Clin Pharmacol; 1988; 35(1):21-4. PubMed ID: 2975595
[TBL] [Abstract][Full Text] [Related]
38. Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
Baez MA; Garg DC; Jallad NS; Weidler DJ
Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):63S-67S. PubMed ID: 2939869
[TBL] [Abstract][Full Text] [Related]
39. A long-term study of doxazosin in the treatment of mild or moderate essential hypertension in general medical practice.
Manos J
Am Heart J; 1991 Jan; 121(1 Pt 2):346-51. PubMed ID: 1824659
[TBL] [Abstract][Full Text] [Related]
40. Double-blind comparison of doxazosin and enalapril in patients with mild or moderate essential hypertension.
Wessels F
Am Heart J; 1991 Jan; 121(1 Pt 2):299-303. PubMed ID: 1824653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
